نتائج البحث - "etanercept"

1

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

المساهمون: HUS Inflammation Center, Department of Medicine, Reumatologian yksikkö, Repositório da Universidade de Lisboa

المصدر: Annals of the Rheumatic Diseases
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Lindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, ' Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration ', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418 . https://doi.org/10.1136/annrheumdis-2021-220097Test

مصطلحات موضوعية: Male, Placebo-controlled study, Psoriatic, PLACEBO-CONTROLLED TRIAL, THERAPY, Etanercept, DOUBLE-BLIND, 0302 clinical medicine, Immunology and Allergy, Medicine, 030212 general & internal medicine, skin and connective tissue diseases, Remission Induction, Middle Aged, Tumour necrosis factor inhibitors, Treatment Outcome, arthritis, Antirheumatic Agents, Drug Therapy, Combination, Female, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Immunology, Psoriatic Arthritis, tumour necrosis factor inhibitors, General Biochemistry, Genetics and Molecular Biology, methotrexate, 03 medical and health sciences, Psoriatic arthritis, Rheumatology, Internal medicine, Adalimumab, Humans, 030203 arthritis & rheumatology, business.industry, Arthritis, Arthritis, Psoriatic, EFFICACY, medicine.disease, Infliximab, Discontinuation, Methotrexate, 3121 General medicine, internal medicine and other clinical medicine, Tumor Necrosis Factor Inhibitors, psoriatic, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022e520d9e5e31bc0cc0baf6321a0476Test
http://europepmc.org/articles/PMC8522446Test

2

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

المؤلفون: Daniel Windschall, Kirsten Minden, Frank Weller-Heinemann, Franz Thiele, Ivan Foeldvari, Ariane Klein, Gerd Horneff, A. Hospach

المصدر: Rheumatology International

مصطلحات موضوعية: musculoskeletal diseases, Male, medicine.medical_specialty, Immunology, Observational Research, Biologics, Opportunistic Infections, Infections, Receptors, Tumor Necrosis Factor, Etanercept, Abatacept, 03 medical and health sciences, chemistry.chemical_compound, Biological Factors, 0302 clinical medicine, Tocilizumab, Rheumatology, Internal medicine, Germany, Adalimumab, medicine, Immunology and Allergy, Humans, Immunologic Factors, 030212 general & internal medicine, Registries, 030203 arthritis & rheumatology, Anakinra, Biological Products, business.industry, Interleukin-6, Tumor Necrosis Factor-alpha, Incidence, Odds ratio, Juvenile idiopathic arthritis, Infliximab, Arthritis, Juvenile, chemistry, Antirheumatic Agents, Immunoglobulin G, Cohort, Female, Safety, business, medicine.drug, Interleukin-1

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1690b55f34c2cea5058075a682e55728Test
http://europepmc.org/articles/PMC7952348Test

3

US rheumatologists’ beliefs and knowledge about biosimilars: a survey

المؤلفون: Dorothy McCabe, Allan Gibofsky

المصدر: Rheumatology (Oxford, England)

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Attitude of Health Personnel, Culture, Etanercept, Food and drug administration, 03 medical and health sciences, 0302 clinical medicine, Biosimilar Pharmaceuticals, Rheumatology, immune system diseases, Internal medicine, Rheumatic Diseases, Surveys and Questionnaires, Adalimumab, Medicine, Humans, Pharmacology (medical), biosimilars, survey, 030212 general & internal medicine, skin and connective tissue diseases, Drug Approval, AcademicSubjects/MED00360, 030203 arthritis & rheumatology, education, business.industry, Drug Substitution, Biosimilar, Clinical Science, Infliximab, United States, Reference product, Social Perception, Attitude, Family medicine, Antirheumatic Agents, Tumor Necrosis Factor Inhibitors, Rheumatologists, business, Rituximab, Needs Assessment, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172c4e9b4eb95ab2d8a41cf76916ef73Test
http://europepmc.org/articles/PMC7850535Test

4

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison

المؤلفون: Philip J. Mease, Howard Thom, Steffen M Jugl, Ernest Choy, K Gandhi, Chrysostomos Kalyvas, Luminita Pricop, Peter Nash, Matthias Hunger

المصدر: European Journal of Rheumatology, Vol 6, Iss 3, Pp 113-121 (2019)
Mease, P J, Choy, E, Nash, P, Kalyvas, C, Hunger, M, Pricop, L, Gandhi, K, Jugl, S & Thom, H 2019, ' Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison ', European Journal of Rheumatology, vol. 6, no. 3, pp. 113-121 . https://doi.org/10.5152/eurjrheum.2019.19057Test

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a7f1619a8309145092fb366ca7284eTest
https://www.eurjrheumatol.org/eng/makale/3224/219/Full-TextTest

5

Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study

المؤلفون: Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova

المصدر: Voprosy Sovremennoj Pediatrii, Vol 18, Iss 1, Pp 31-40 (2019)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a04a6b1553a721ec31190a3d74557c1Test
https://vsp.spr-journal.ru/jour/article/view/2023Test

6

Uptake of Biosimilars and Its Economic Implication for the Treatment of Patients with Rheumatoid Arthritis in Korea

المؤلفون: Sun Young Jung, Hyoungyoung Kim, Soo-Kyung Cho, Kyung-Eun Lee, Yeo Jin Song, Yoon Kyoung Sung

المصدر: Journal of Korean Medical Science

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Biologics, Etanercept, Arthritis, Rheumatoid, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, Immunology, Allergic Disorders & Rheumatology, Republic of Korea, medicine, Adalimumab, Trend, Humans, 030212 general & internal medicine, Intensive care medicine, skin and connective tissue diseases, Biosimilar Pharmaceuticals, business.industry, Abatacept, Biosimilar, General Medicine, Health Care Costs, medicine.disease, Infliximab, Golimumab, Treatment Outcome, chemistry, Rheumatoid arthritis, Antirheumatic Agents, Original Article, Tumor Necrosis Factor Inhibitors, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b700ad0a5f2f9791759ce8e73ae12cc3Test
http://europepmc.org/articles/PMC8144596Test

7

ETANERCEPT TREATMENT RESULTS IN CHILDREN WITH NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REMISSION, RECRUDESCENCE, AND ADVERSE EVENTS. RETROSPECTIVE COHORT STUDY

المؤلفون: Mikhail M. Kostik, Irina A. Chikova, Eugenia A. Isupova, Maria N. Likhacheva, Tatyana S. Likhacheva, Margaruta F. Dubko, Vera V. Masalova, Ludmila S. Snegireva, Ekaterina V. Gaidar, Olga V. Kalashnikova, Vyacheslav G. Chasnyk

المصدر: Voprosy Sovremennoj Pediatrii, Vol 17, Iss 2, Pp 138-147 (2018)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0a08f87705e3294c42619fb7fe3108Test
https://vsp.spr-journal.ru/jour/article/view/1883Test

8

Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases

المؤلفون: L. Lojo, Marta García-Castro, Teresa Navío, Marina Salido, Jose Yuste, Laura González-Hombrado, T. Cobo, Santiago Muñoz-Fernández, María Dolores Martín, Ana Jiménez-Diaz, Patricia Richi, Patricia Castro, Laura Cebrián, Israel Thuissard-Vasallo, Jesús Llorente, Martina Steiner

المساهمون: Sociedad Madrileña de Reumatología, Ministerio de Economía, Industria y Competitividad (España)

المصدر: Vaccines, Vol 9, Iss 203, p 203 (2021)
Vaccines
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Volume 9
Issue 3
Repisalud
Instituto de Salud Carlos III (ISCIII)

مصطلحات موضوعية: musculoskeletal diseases, anti-TNFα, Immunology, Inmunología, lcsh:Medicine, Salud, PCV13, Inflammatory bowel disease, invasive pneumococcal disease, Article, Etanercept, 03 medical and health sciences, chemistry.chemical_compound, tocilizumab, 0302 clinical medicine, Tocilizumab, rituximab, Enfermedades autoinmunes, PPV23, Autoimmune inflammatory diseases, Drug Discovery, medicine, Adalimumab, Biological therapy, Pharmacology (medical), 030212 general & internal medicine, 030203 arthritis & rheumatology, Pharmacology, Anakinra, business.industry, Abatacept, lcsh:R, Invasive pneumococcal disease, OPKA titers, medicine.disease, Vaccination, Infectious Diseases, chemistry, Terapia, biological therapy, Rituximab, business, autoimmune inflammatory diseases, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1559f98e3402bddd7d05225516735e29Test
https://www.mdpi.com/2076-393X/9/3/203Test

9

Etanercept – A culprit agent in acute pancreatitis?

المؤلفون: Beenish Fayyaz, Tania Octaria Mihardja, Ferry Gunawan

المصدر: Journal of Community Hospital Internal Medicine Perspectives
Journal of Community Hospital Internal Medicine Perspectives, Vol 9, Iss 2, Pp 147-149 (2019)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c1f9e512d62ba5294dc02de5293ea4Test
http://europepmc.org/articles/PMC6484468Test

10

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial

المؤلفون: Christopher T. Ritchlin, Philip J. Mease, David H. Collier, Philip S. Helliwell, Lyrica Liu, Dafna D. Gladman, Gregory Kricorian, James B. Chung

المصدر: Arthritis & Rheumatology (Hoboken, N.j.)

مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Combination therapy, Inflammatory arthritis, Immunology, Psoriatic Arthritis, Arthritis, Placebo, Gastroenterology, Receptors, Tumor Necrosis Factor, Etanercept, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Rheumatology, Double-Blind Method, Internal medicine, medicine, Immunology and Allergy, Humans, 030212 general & internal medicine, skin and connective tissue diseases, 030203 arthritis & rheumatology, business.industry, Arthritis, Psoriatic, Middle Aged, medicine.disease, Methotrexate, Antirheumatic Agents, Drug Therapy, Combination, Female, Tumor Necrosis Factor Inhibitors, Original Article, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1cbca88127f566f22a4a9c653c67de6Test
http://europepmc.org/articles/PMC6618246Test

تنقيح النتائج